Fig. 1

The medicine adoption model: PH − (non-pharmaceutical company stakeholder groups); PH + (pharmaceutical company stakeholder groups)
The medicine adoption model: PH − (non-pharmaceutical company stakeholder groups); PH + (pharmaceutical company stakeholder groups)